A video conference of the Ireland/Northern Ireland Specialised Committee was held early November exchanging updates on the implementation of the so called Northern Ireland Protocol. The meeting was co-chaired by officials

In view of recent experiences from inspections carried out for COVID-19 therapeutics, the World Health Organization (WHO) published a new working document entitled “GOOD MANUFACTURING PRACTICES FOR INVESTIGATIONAL PRODUCTS“. The

On 02 September, the UK Medicine and Healthcare Agency MHRA has published a Guidance called “Importing Medicines on an approved country for import list from 1 January 2021“.  This Guideline

The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has joined the Australia-Canada-Singapore-Switzerland (ACSS) Consortium. The ACSS consortium was formed in 2007 and comprised the national regulatory authorities of Australia,

A pharmaceutical company in the US shipped an over-the counter (OTC) drug product three days before receiving the certificate of analysis (COA) from their contract laboratory. This COA included assay results for the active